Trial Profile
Retrospective study of men undergoing stereotactic body radiotherapy (SBRT) for oligometastatic prostate cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2016
Price :
$35
*
At a glance
- Drugs Abiraterone (Primary) ; Docetaxel (Primary) ; Enzalutamide (Primary) ; Sipuleucel-T (Primary) ; Technetium-99m (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 12 Aug 2016 New trial record